01.01.04
BioGaia AB, Stockholm, Sweden, has signed an agreement with a European subsidiary of the multinational pharmaceutical company C.B. Fleet, Inc., Lynchburg, VA, giving Fleet an exclusive license to sell LifeTop™ Straw, which is a straw containing the lactic acid bacterium Lactobacillus reuteri (Reuteri™) that can be attached to the side of a package. Upon consumption, Reuteri is released and administered to the consumer together with the beverage. The license agreement is valid for three years and gives Fleet the exclusive right to market and sell LifeTop Straw in hospitals and pharmacies. In addition, the agreement offers Fleet the possibility of extending the rights to other European markets. The launch is planned for April 2004.